Charité - Universitätsmedizin Berlin

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials (2021) Denkert C, Seither F, Schneeweiss A, Link T, Blohmer JU, Just M, Wimberger P, et al. Journal article Heart rate variability predicts decline in sensorimotor rhythm control (2021) Nann M, Haslacher D, Colucci A, Eskofier B, Von Tscharner V, Soekadar SR Journal article Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy (2021) Marmé F, Solbach C, Michel L, Schneeweiss A, Blohmer JU, Huober J, Fasching P, et al. Journal article Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumors (2021) Uhlig J, Uhlig A, Bachanek S, Onur MR, Kinner S, Geisel D, Kohler M, et al. Journal article Sample Curriculum of the German Society for Rheumatology for Advanced Training in the field of Internal Medicine and Rheumatology (2021) Pfeil A, Krusche M, Vossen D, Berliner MN, Keyer G, Krause A, Lorenz HM, et al. Journal article, Editorial Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy (2021) Bojarski C, Waldner M, Rath T, Schürmann S, Neurath M, Atreya R, Siegmund B Journal article, Review article Criteria of the German Cardiac Society (DGK), the German Hypertension League DHL (R)/German Society for Hypertension and Prevention and the German Society for Nephrology (DGfN) on certification of renal denervation centers (RDZ)-Update (2021) Mahfoud F, Galle J, Schunkert H, Schmieder R, Rump LC, Limbourg FP, Van Der Giet M, et al. Journal article Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' Perspectives (2021) Willems LM, Rosenow F, Schubert-Bast S, Kurlemann G, Zoellner JP, Bast T, Bertsche A, et al. Journal article Skin sodium is increased in male patients with multiple sclerosis and related animal models (2021) Huhn K, Linz P, Pemsel F, Michalke B, Seyferth S, Kopp C, Chaudri MA, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article